Copyright
©The Author(s) 2016.
World J Diabetes. May 10, 2016; 7(9): 189-197
Published online May 10, 2016. doi: 10.4239/wjd.v7.i9.189
Published online May 10, 2016. doi: 10.4239/wjd.v7.i9.189
Table 1 Physiological actions of amylin
Neuroendocrine effects |
Inhibiting insulin secretion in a high concentration |
Inhibiting glucagon secretion at mealtime |
Delaying nutrient delivery from stomach to the small intestine |
Reducing food intake by a signal from the central nervous system |
Metabolic effects |
Co-regulating glucose with insulin and glucagon |
Inhibiting muscle glycogen synthesis[15] |
Stimulating oxidative responses and low density lipoprotein uptake in insulin-producing cells |
Inhibiting bone resorption |
Lipolytic-like effects |
Renal effects |
Renin ↑ |
Angiotensin II ↑ |
Regulating renal growth |
Regulating water-sodium homeostasis |
Haemodynamic effect |
Aldosterone ↑ |
Hypocalcaemia |
Vasodilation |
- Citation: Zhang XX, Pan YH, Huang YM, Zhao HL. Neuroendocrine hormone amylin in diabetes. World J Diabetes 2016; 7(9): 189-197
- URL: https://www.wjgnet.com/1948-9358/full/v7/i9/189.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i9.189